Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CDK4 | P11802 | 1/20 | 0.43 |
| ▸ | CCND1 | P24385 | 1/20 | 0.43 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.42 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.42 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.42 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.42 |
| ▸ | PRKAG3 | Q9UGI9 | 1/20 | 0.42 |
| ▸ | PRKAG2 | Q9UGJ0 | 1/20 | 0.42 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.42 |
| ▸ | GSK3A | P49840 | 2/20 | 0.41 |
| ▸ | GSK3B | P49841 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7257484 | 0.85 | KDM4E (0.46) | KDM4EDYRK1AADORA2AKMT2AMEN1 | |
| SCHEMBL7256732 | 0.84 | KDM4E (0.44) | KDM4EDYRK1AADORA2AKMT2AMEN1 | |
| SCHEMBL12692214 | 0.81 | ADORA1 (0.49) | KDM4EDYRK1AADORA2AKMT2AMEN1 | |
| SCHEMBL10333750 | 0.71 | PDE3B (0.54) | KDM4EKMT2AMEN1CDK4POLB | |
| SCHEMBL2090637 | 0.71 | NCF1 (0.47) | KDM4EKMT2AMEN1MAPTPOLB | |
| SCHEMBL7256520 | 0.70 | MEN1 (0.47) | KDM4EDYRK1AKMT2AMEN1CDK4 | |
| SCHEMBL6116321 | 0.70 | BTK (0.69) | DYRK1AACHE | |
| SCHEMBL29930500 | 0.69 | DYRK1A (0.47) | KDM4EDYRK1AADORA2AKMT2AMEN1 | |
| SCHEMBL11940604 | 0.69 | MEN1 (0.52) | DYRK1AKMT2AMEN1GSK3AGSK3B | |
| SCHEMBL3364101 | 0.68 | JAK2 (0.66) | DYRK1APRKAG1PRKAA1PRKAB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11773121-B2 | Antiviral compounds | VIROVAX LLC (US) | 2023-10-03 | — | — | US | disclosed |
| US-20210238210-A1 | ANTIVIRAL COMPOUNDS | VIROVAX LLC | 2021-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210238210-A1 | ANTIVIRAL COMPOUNDS | ZC3HAV1, SARS1, ZC3HAV1L | KDM4E 2111/4885DYRK1A 3332/4885ADORA2A 1925/4885 |
| US-11773121-B2 | Antiviral compounds | ZC3HAV1, SARS1, ZC3HAV1L | KDM4E 2111/4885DYRK1A 3332/4885ADORA2A 1925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.